COPD patients prescribed inhaled corticosteroid in primary care: time for re-assessment based on exacerbation rate and blood eosinophils?

BACKGROUND AND OBJECTIVE: Inhaled corticosteroid (ICS) therapy for COPD should be guided by exacerbations and blood-eosinophils according to the GOLD 2020 strategy document. In the present study, we applied these recent recommendations in a large cohort of COPD patients recruited from general practi...

Descripción completa

Detalles Bibliográficos
Autores principales: Savran, Osman, Godtfredsen, Nina, Sørensen, Torben, Jensen, Christian, Ulrik, Charlotte Suppli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881579/
https://www.ncbi.nlm.nih.gov/pubmed/33579297
http://dx.doi.org/10.1186/s12931-021-01651-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881579/
https://www.ncbi.nlm.nih.gov/pubmed/33579297
http://dx.doi.org/10.1186/s12931-021-01651-w

Ejemplares similares